You are here

Oncogene DOI:10.1038/onc.2012.315

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.

Publication TypeJournal Article
Year of Publication2013
AuthorsWang, P, Dong, Q, Zhang, C, Kuan, P-F, Liu, Y, Jeck, WR, Andersen, JB, Jiang, W, Savich, GL, Tan, T-X, Auman, JT, Hoskins, JM, Misher, AD, Moser, CD, Yourstone, SM, Kim, JW, Cibulskis, K, Getz, G, Hunt, HV, Thorgeirsson, SS, Roberts, LR, Ye, D, Guan, K-L, Xiong, Y, Qin, L-X, Chiang, DY
JournalOncogene
Volume32
Issue25
Pages3091-100
Date Published2013 Jun 20
ISSN1476-5594
KeywordsBase Sequence, Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Brain Neoplasms, Cholangiocarcinoma, CpG Islands, DNA Methylation, Glioblastoma, Histones, Humans, Isocitrate Dehydrogenase, Liver Neoplasms, Mutation, Neoplasm Recurrence, Local, Sequence Analysis, DNA, Tumor Suppressor Protein p53
Abstract

Mutations in the genes encoding isocitrate dehydrogenase, IDH1 and IDH2, have been reported in gliomas, myeloid leukemias, chondrosarcomas and thyroid cancer. We discovered IDH1 and IDH2 mutations in 34 of 326 (10%) intrahepatic cholangiocarcinomas. Tumor with mutations in IDH1 or IDH2 had lower 5-hydroxymethylcytosine and higher 5-methylcytosine levels, as well as increased dimethylation of histone H3 lysine 79 (H3K79). Mutations in IDH1 or IDH2 were associated with longer overall survival (P=0.028) and were independently associated with a longer time to tumor recurrence after intrahepatic cholangiocarcinoma resection in multivariate analysis (P=0.021). IDH1 and IDH2 mutations were significantly associated with increased levels of p53 in intrahepatic cholangiocarcinomas, but no mutations in the p53 gene were found, suggesting that mutations in IDH1 and IDH2 may cause a stress that leads to p53 activation. We identified 2309 genes that were significantly hypermethylated in 19 cholangiocarcinomas with mutations in IDH1 or IDH2, compared with cholangiocarcinomas without these mutations. Hypermethylated CpG sites were significantly enriched in CpG shores and upstream of transcription start sites, suggesting a global regulation of transcriptional potential. Half of the hypermethylated genes overlapped with DNA hypermethylation in IDH1-mutant gliobastomas, suggesting the existence of a common set of genes whose expression may be affected by mutations in IDH1 or IDH2 in different types of tumors.

URLhttp://dx.doi.org/10.1038/onc.2012.315
DOI10.1038/onc.2012.315
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/22824796?dopt=Abstract

Alternate JournalOncogene
PubMed ID22824796
PubMed Central IDPMC3500578
Grant ListR01 CA149569 / CA / NCI NIH HHS / United States
R01 CA163834 / CA / NCI NIH HHS / United States
R01 HG006272 / HG / NHGRI NIH HHS / United States